Human embryonic stem cells used to restore sight in two patients — our expert gives his view on the breakthrough

In response to the use of embryonic stem cells to restore vision in two patients with macular degeneration, WideCells Group CSO Professor Peter Hollands provides insight into the history – and his personal experience of — this controversial branch of regenerative medicine:

Human embryonic stem cells

A recent report on the use of human embryonic stem cells to treat a damaged retina and restore vision is very encouraging.

Two patients, a man in his 80s and a woman in her 60s, received embryonic stem cell grafts to their eyes to treat age-related macular degeneration. The result has been the restoration of normal vision in these patients with no side effects. They can now see well enough to read. Further clinical trials are needed but the benefits to these two patients are clear.

Ethical concerns

In the early 1980s I was a Clinical Embryologist at Bourn Hall Clinic which was the first in vitrofertilisation clinic in the world. I was working under the supervision of Prof R.G. Edwards and Mr P.C. Steptoe who had created the first ‘test-tube’ baby in 1978. These were pioneering days and it was an honour to be part of the team bringing this new technology to the world.

Each day I would look down the microscope in the dimly lit laboratory and see human embryos growing and thriving. It was interesting to think that, at that time, I was one of the very few people in the world who had seen a living human embryo. When the team discussed our work we all agreed that within the embryos we were seeing there would be stem cells which would eventually develop into the fetus, the placenta and the membranes of pregnancy.

What we did not know at that stage was whether or not it would be possible to extract and manipulate these human embryonic stem cells. My PhD at Cambridge University had investigated the possibility of finding stem cells in early implantation mouse embryos. This work not only showed that stem cells were present but that they could be used to repair the bone marrow of other mice and even cure a genetic anaemia in a particular strain of mice.

The stage was set for the discovery and manipulation of embryonic stem cells but we also knew that such technology would bring much opposition. We had already faced severe opposition for the development of IVF from religious, ethical, legal and moral groups so taking this to the next step for embryonic stem cells would be a great challenge for those involved. My own interests moved away from embryonic stem cells to adult stem cells, such as bone marrow, cord blood, cord tissue, teeth and so on — and this has been my focus of attention ever since.

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    WideCells Group PLC

    More articles like this

    WideCells Group PLC

    Wonder stem cell cure for heart failure

    MILLIONS of heart failure patients could be saved thanks to a new stem cell therapy being tested in Britain. Researchers yesterday revealed a breakthrough treatment that cuts out the need for operations by revitalising damaged tissue

    WideCells Group PLC

    Cord Blood Stem Cells

    Umbilical cord blood stem cells are currently being used to treat more than 80 diseases and disorders, such as leukaemias and aneamias. What are cord blood stem cells? Stem cells found in cord blood are haemopoietic (blood forming). Haemopoietic stem

    WideCells Group PLC

    Why Widecells?

    What’s more important than your health and that of your family? At WideCells we are leading a transformation in stem cell services and stem cell treatment to give you new and better healthcare options. It’s our

    WideCells Group PLC

    What are stems cells?

    It’s estimated that 1 in 3 of us will need a stem cell transplant in our lifetime. What are stem cells? Stem cells are essential for the normal health and functioning of the body, during both development

    WideCells Group PLC

    YOUR BABYCELLS JOURNEY

    Congratulations! No doubt you’re glowing in your pregnancy. With advice and tips coming from all directions, naturally,  as part of your journey you will be wondering how best to protect your family’s future. Your thoughts With

    WideCells Group PLC

    WideCells Group PLC Get Conviction Buy Stance from Align Research

    WideCells Group PLC (LON:WDC), the healthcare services company focused on providing stem cell services and ground-breaking insurance for stem cell treatment, has today announced that following the Group’s recent placing, Align Research has released an update note

    WideCells Group PLC

    INTERVIEW: Widecells Group Placing and Looking ahead

    Widecells Group Plc (LON:WDC) CEO João Andrade & CFO David Bridgland talk to DirectorsTalk about the lifting of a trading suspension. João explains why the shares were suspended, if anything was hindered as a result and

    WideCells Group PLC

    Wonder stem cell cure for heart failure

    Millions of heart failure patients could be saved thanks to a new stem cell therapy being tested in Britain. Researchers revealed a breakthrough treatment that cuts out the need for operations by revitalising damaged tissue using

    WideCells Group PLC

    WideCells Group PLC Placing Update and Financial Position

    WideCells Group PLC (LON:WDC) the healthcare services company focused on providing stem cell services and ground-breaking insurance for stem cell treatment, provides the following update on its financial position. As announced on 5 June 2018, the

    WideCells Group PLC

    WideCells Group PLC Audited Preliminary Results

    WideCells Group PLC (LON:WDC), the healthcare services company focused on providing stem cell services and ground-breaking insurance for stem cell treatment, announced today its audited preliminary results for the period ended 31 December 2017. Copies of the

    WideCells Group PLC

    Why do we have blood types?

    More than a century after their discovery, we still don’t really know what blood types are for. Do they really matter? Carl Zimmer investigates. When my parents informed me that my blood type was A+, I

    WideCells Group PLC

    How synthetic DNA could be used as a sensor

    Konstantinos Vavitsas, The University of Queensland Researchers believe that DNA – the molecule that stores information about life – could one day be used as a type of sensor, to record information based on its surroundings. Synthetic